Cara Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Cara Therapeutics has a total shareholder equity of $707.0K and total debt of $40.6M, which brings its debt-to-equity ratio to 5740.2%. Its total assets and total liabilities are $51.3M and $50.6M respectively.
Key information
5,740.2%
Debt to equity ratio
US$40.58m
Debt
| Interest coverage ratio | n/a |
| Cash | US$42.04m |
| Equity | US$707.00k |
| Total liabilities | US$50.62m |
| Total assets | US$51.33m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 69C's short term assets ($47.9M) exceed its short term liabilities ($10.0M).
Long Term Liabilities: 69C's short term assets ($47.9M) exceed its long term liabilities ($40.6M).
Debt to Equity History and Analysis
Debt Level: 69C has more cash than its total debt.
Reducing Debt: 69C's debt to equity ratio has increased from 0% to 5740.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 69C has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 69C has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.4% each year